The increase in RDW can be attributed to activated inflammatory response in HF on the one hand, and increased inflammatory factors, including IL-1β, TNF-α, and IL-6 that suppress erythropoiesis thereby elevating RDW on the other, as well as insufficient EPO production in HF that causes anemia, also contributing to elevated RDW. Here, IL6 is linked to anemia.